Publication:
THE ANALYSIS OF THE INFLAMMATORY PROTEOME IN RHEUMATOID ARTHRITIS IDENTIFIES COMMON SIGNATURES ASSOCIATED WITH THE CLINICAL RESPONSE TO DMARDS AND TNFI THERAPIES

dc.contributor.authorMunoz-Barrera, L.
dc.contributor.authorPerez-Sanchez, C.
dc.contributor.authorContreras, A. Escudero
dc.contributor.authorAguirre-Zamorano, M. A.
dc.contributor.authorGutierrez, J. Calvo
dc.contributor.authorCastro, R. Ortega
dc.contributor.authorRomero-Gomez, M.
dc.contributor.authorSanchez-Pareja, I.
dc.contributor.authorAbalos-Aguilera, M. C.
dc.contributor.authorPuerto, N. Barbarroja
dc.contributor.authorVenegas, J. J. Perez
dc.contributor.authorRuiz-Montesinos, D.
dc.contributor.authorRodriguez-Escalera, C.
dc.contributor.authorRomero-Barco, C. M.
dc.contributor.authorMena-Vazquez, N.
dc.contributor.authorFernandez-Nebro, A.
dc.contributor.authorUceda, J.
dc.contributor.authorMarenco, J. L.
dc.contributor.authorEstevez, E. Collantes
dc.contributor.authorLopez-Pedreraon, C.
dc.contributor.authoraffiliation[Munoz-Barrera, L.] Univ Cordoba, Rheumatol, IMIBIC Reina Sofia Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Perez-Sanchez, C.] Univ Cordoba, Rheumatol, IMIBIC Reina Sofia Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Contreras, A. Escudero] Univ Cordoba, Rheumatol, IMIBIC Reina Sofia Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Aguirre-Zamorano, M. A.] Univ Cordoba, Rheumatol, IMIBIC Reina Sofia Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Gutierrez, J. Calvo] Univ Cordoba, Rheumatol, IMIBIC Reina Sofia Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Castro, R. Ortega] Univ Cordoba, Rheumatol, IMIBIC Reina Sofia Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Romero-Gomez, M.] Univ Cordoba, Rheumatol, IMIBIC Reina Sofia Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Sanchez-Pareja, I.] Univ Cordoba, Rheumatol, IMIBIC Reina Sofia Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Abalos-Aguilera, M. C.] Univ Cordoba, Rheumatol, IMIBIC Reina Sofia Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Puerto, N. Barbarroja] Univ Cordoba, Rheumatol, IMIBIC Reina Sofia Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Estevez, E. Collantes] Univ Cordoba, Rheumatol, IMIBIC Reina Sofia Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Lopez-Pedreraon, C.] Univ Cordoba, Rheumatol, IMIBIC Reina Sofia Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Venegas, J. J. Perez] Hosp Univ Virgen Macarena, Rheumatol, Seville, Spain
dc.contributor.authoraffiliation[Ruiz-Montesinos, D.] Hosp Univ Virgen Macarena, Rheumatol, Seville, Spain
dc.contributor.authoraffiliation[Rodriguez-Escalera, C.] Hosp Clin Univ, Rheumatol, Malaga, Spain
dc.contributor.authoraffiliation[Romero-Barco, C. M.] Hosp Clin Univ, Rheumatol, Malaga, Spain
dc.contributor.authoraffiliation[Mena-Vazquez, N.] Hosp Reg Univ Malaga, Rheumatol, Malaga, Spain
dc.contributor.authoraffiliation[Fernandez-Nebro, A.] Hosp Reg Univ Malaga, Malaga, Spain
dc.contributor.authoraffiliation[Uceda, J.] Hosp Univ Virgen Valme, Rheumatol, Seville, Spain
dc.contributor.authoraffiliation[Marenco, J. L.] Hosp Univ Virgen Valme, Rheumatol, Seville, Spain
dc.contributor.funderISCIII
dc.contributor.funderFEDER
dc.contributor.funderConsejeria de Conocimiento, Investigacion y Universidad de la Junta de Andalucia
dc.contributor.funderFundacion Andaluza de Reumatologia (FAR)
dc.date.accessioned2023-05-03T13:30:55Z
dc.date.available2023-05-03T13:30:55Z
dc.date.issued2022-06-01
dc.description.abstractBackground: The clinical outcome of the most common therapeutic options of rheumatoid arthritis (RA) patients, such as conventional disease-modifying antirheumatic drugs (DMARDs) and TNF inhibitors (TNFi) is still unpredictable, since a high percentage of patients do not response to the therapy. Innovative analyses combining high-throughput technologies and thorough clinical assessments are needed to gain insight about the management of this prevalent autoimmune disorder.
dc.description.versionSi
dc.identifier.citationMuñoz-Barrera L, Perez-Sanchez C, Contreras AE, Aguirre-Zamorano MÁ, Gutierrez JC, Castro RO, et al. POS0440 THE ANALYSIS OF THE INFLAMMATORY PROTEOME IN RHEUMATOID ARTHRITIS IDENTIFIES COMMON SIGNATURES ASSOCIATED WITH THE CLINICAL RESPONSE TO DMARDs AND TNFI THERAPIES. Annals Of The Rheumatic Diseases [Internet]. 23 de mayo de 2022;81(Suppl 1):475.1-475
dc.identifier.doi10.1136/annrheumdis-2022-eular.4466
dc.identifier.essn1468-2060
dc.identifier.issn0003-4967
dc.identifier.unpaywallURLhttps://ard.bmj.com/content/annrheumdis/81/Suppl_1/475.1.full.pdf
dc.identifier.urihttp://hdl.handle.net/10668/20117
dc.identifier.wosID850279001376
dc.issue.number1
dc.journal.titleAnnals of the rheumatic diseases
dc.journal.titleabbreviationAnn. rheum. dis.
dc.language.isoen
dc.organizationHospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba-IMIBIC
dc.organizationHospital Universitario Virgen de la Victoria
dc.organizationHospital Universitario Regional de Málaga
dc.organizationHospital Universitario Virgen del Rocío
dc.organizationHospital Universitario Virgen Macarena
dc.organizationAGS - Sur de Sevilla
dc.page.number475-475
dc.provenanceRealizada la curación de contenido 17/02/2025
dc.publisherBMJ Group
dc.relation.projectIDPI21/005991
dc.relation.projectIDRICOR-RD21/0002/0033
dc.relation.projectIDP20_01367
dc.relation.publisherversionhttps://ard.bmj.com/content/81/Suppl_1/475.1
dc.rights.accessRightsopen access
dc.titleTHE ANALYSIS OF THE INFLAMMATORY PROTEOME IN RHEUMATOID ARTHRITIS IDENTIFIES COMMON SIGNATURES ASSOCIATED WITH THE CLINICAL RESPONSE TO DMARDS AND TNFI THERAPIES
dc.typeConference output
dc.type.hasVersionVoR
dc.volume.number81
dc.wostypeMeeting Abstract
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
RISalud_Accesorestringido.pdf
Size:
93.39 KB
Format:
Adobe Portable Document Format